Single-use Bioprocessing Probes And Sensors Market Size, Share & Trends Analysis Report By Workflow (Downstream, Upstream), By Sensor Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global single-use bioprocessing probes and sensors market size was estimated at USD 2.75 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.87% from 2023 to 2030. The growth can be attributed to increasing demand for biopharmaceuticals and the growing acceptance of disposable systems in pre-clinical stages. In addition, the commercial benefits of the products are fueling the market for single-use bioprocessing probes and sensors. The COVID-19 pandemic positively impacted the market growth. The market has witnessed revenue growth and increased adoption during the pandemic. The opportunities were created to provide novel applications of single-use solutions, such as sensors. Technology suppliers collaborated with bio manufacturers to meet the increasing demand for vaccines and therapeutics.

For instance, Serum Institute of India Pvt. Ltd. (SIIPL) partnered with ABEC to use the company’s single-use technologies to produce around one billion doses of the COVID-19 vaccine Novavax. Moreover, the company’s operating in the market registered increased demand driving revenue growth during the COVID-19 pandemic. For instance, Thermos Fisher Scientific, Inc., a major player in the market, reported a USD 2 billion revenue in the third quarter of 2020 owing to the increased demand for COVID-19-related products, including single-use lab supplies for vaccines and therapies. Moreover, the rising prevalence of chronic disorders, including autoimmune and cancer, is propelling the growth of the market. The International Agency for Research on Cancer (IARC) estimates that about 16.3 million cancer deaths may occur by 2040.

The solutions and products of the market offer various benefits to patients suffering from chronic diseases, such as less downtime, lowered risk of contamination, and decreased initial costs. These products aid in the timely and accurate monitoring of pH, dissolved oxygen, and temperature levels. With the growing prevalence of chronic disorders and the increasing utility & benefits of single-use bioprocessing probes and sensors, the market is anticipated to showcase significant growth over the forecast period. In addition, the commercial benefits of the products over stainless-steel bioprocessing products are anticipated to fuel market growth. The single-use methods for clinical production eliminate the substantial expense required for stainless steel facilities.

They are designed to be disposable and eliminate the need for time-consuming & costly cleaning and sterilization processes. Moreover, single-use facilitates process portability from one place to another. Furthermore, the associations between OEMs and sensor suppliers provide comprehensive single-use assemblies. For instance, in January 2023, Qosina, a provider of OEM single-use elements, partnered with ILC Dover. This partnership aimed to expand the product portfolio of Qosina to include liquid single-use chamber bags. In addition, through this partnership, ILC Dover assured the supply of Qosina's single-use bioprocess systems. Such associations are aimed at accelerating the use of single-use products.

Sensor Type Insights

Based on the sensor type, the market is segmented into sensors of pH, oxygen, pressure, temperature, conductivity, flow sensors, and others. pH sensors accounted for the largest market share of 19.93% in 2022 and are expected to grow at the fastest CAGR during the forecast period. It is one of the vital products that is generally utilized for water measurements. These sensors help measure the acidity and alkalinity of water in other solutions. Factors, such as the high usage rate and increasing product penetration, have propelled the segment growth and demand. Moreover, technological advances in the segment, such as pH sensors with an in-built temperature sensor, are anticipated to fuel the segment's growth over the forecast period.

The oxygen sensors segment is projected to grow at a lucrative CAGR of 12.95% from 2023 to 2030. Factors, such as the increasing prevalence of chronic disorders and the development of disposable sensors, are projected to drive a high growth rate in the segment. Moreover, many disposable sensors facilitate users to measure Dissolved Oxygen (DO) separately. DO level measurement is the physicochemical parameter monitored mostly in bioprocessing engineering. Several companies engaged in marketing and manufacturing disposable sensors to measure DO include Hamilton Company; Eppendorf AG; Applikon Biotechnology, Inc., Finesse; and Polestar Technologies.

Workflow Insights

On the basis of workflow, the market is segmented into upstream and downstream. The upstream segment dominated the market with a revenue share of 73.49% in 2022. The high revenue share of the segment is attributed to the increasing adoption of single-use media bags and bioreactors by manufacturers involved in the upstream manufacturing process.An effective upstream method typically depends on identifying Critical Process Parameters (CPPs) and using a bioreactor sensor type, which can deliver adequate control over CPPs. In an upstream process, Critical Process Parameters (CPPs) that are typically scrutinized comprise Dissolved Oxygen (DO), temperature, and pH.

Moreover, additional factors, such as viable-cell density, culture viability, specific growth rate, nutrient levels, and other measurable parameters are considered CPPs. The downstream processing is projected to register a lucrative CAGR of 11.76% from 2023 to 2030. The purification/polishing and affinity capture steps are considered expensive in this process. The continuous efforts by key players operating in the market to increase the use of disposables in the downstream process are anticipated to support the segment's growth over the forecast period.

End-use Insights

The biopharmaceutical & pharmaceutical companies segment accounted for the largest revenue share of 42.05% in 2022. Consistent new product developments in the market are driving the segment's growth. Moreover, increased adoption of disposables among in-house bio manufacturers to efficiently fulfill the worldwide rising demand for biopharmaceuticals is one of the major aspects of the growth of the biopharmaceutical manufacturer segment.

The academic & research institutes segment is anticipated to register the fastest CAGR of 15.12% from 2023 to 2030. The factors attributed to the growth of the segment include increasing research & development activities in the fields of biotechnology, pharmaceuticals & bioengineering. The research activities need accurate and reliable data, which drives the demand for single-use bioprocessing probes and sensors. Moreover, the advantages of single-use probes and sensors over traditional ones are anticipated to drive their demand over the forecast period.

Regional Insights

North America dominated the market with a share of 40.37% in 2022. The regional market covers two countries, i.e., the U.S. and Canada. The dominance of the region is due to the existence of several biopharmaceutical manufacturers in the U.S. These manufacturers include FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; DPx Holdings; CMC Biologics; Amgen; and AbbVie, Inc. Many companies operating in the region undertake steps associated with bioprocessing. In addition, the region is home to various small- and large-scale OEMs like Entegris, Inc., PBS Biotech, Inc., Thermo Fisher, GE Healthcare, and Pall Corporation. These players contribute to the large market share of the region. The rising investment in the market is also propelling the region’s growth. For instance, in February 2022, Thermo Fisher Scientific, Inc., invested USD 40 million for the expansion of its single-use technology manufacturing facility in Pennsylvania.

These factors support the regional market growth in the industry. Asia Pacific is expected to grow at a significant CAGR of 12.70% from 2023 to 2030. The recognition and emergence of countries in the Asia Pacific as a hub for biopharmaceutical outsourcing will support the region’s growth. In addition, major industry players are focusing on expanding into Asian countries. For instance, in January 2023, Thermo Fisher Scientific, Inc. revealed the launch of a new manufacturing facility in China. The facility utilizes single-use technologies to manufacture drug substances and products and is expected to support a wide range of production volumes and scales. The presence of emerging economies, such as China and India, and the introduction of disposable products by bio manufacturers are driving the market growth.

Key Companies & Market Share Insights

The key players are undertaking different strategic initiatives to maintain their industry presence and strengthen their business position. The prominent strategies adopted by companies include product launches, partnerships, collaborations, geographical expansions, and mergers & acquisitions. For instance, in June 2023, High Purity New England, a key market participant, partnered with Fannin to distribute their products in Ireland. Many products of the company, including single-use and multi-use pumps, custom single-use assemblies, and others, are expected to be supplied by Fannin. Some of the key players in the global single-use bioprocessing probes and sensors market include:

• Thermo Fisher Scientific

• Sartorius AG

• Danaher

• PreSens Precision Sensing GmbH

• ABEC

• Hamilton Company

• PendoTECH LLC

• Equflow

• Parker Hannifin Corporation

• Dover Corporation

Single-use Bioprocessing Probes And Sensors Market Report Scope

Global Single-use Bioprocessing Probes And Sensors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global single-use bioprocessing probes and sensors market report on the basis of sensor type, workflow, end-use, and region:

• Sensor Type Outlook (Revenue, USD Million, 2018 - 2030)

  • pH Sensor

  • Oxygen Sensor

  • Pressure Sensors

  • Temperature Sensors

  • Conductivity Sensors

  • Flow Meters & Sensors

  • Others

• Workflow Outlook (Revenue, USD Million, 2018 - 2030)

  • Upstream

  • Downstream

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Biopharmaceutical & Pharmaceutical Companies

  • CROs & CMOs

  • Academic & Research Institutes

  • Other End-users

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait